Could amniotic fluid mist help heal scarred lungs?
NCT ID NCT07372989
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests whether inhaling a mist made from donated human amniotic fluid is safe for people with interstitial lung disease (ILD), a condition that scars the lungs and makes breathing hard. About 50 adults aged 40 to 90 with mild to moderate ILD will receive the treatment. The goal is to check for side effects and see if lung function improves.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG DISEASES, INTERSTITIAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Maule Stem Cell Research Institute
RECRUITINGVenice, Florida, 34292, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can scans replace breathing tests to monitor lung scarring?
- Skin patch could replace needle sticks during exercise tests
- Pigeon Lovers' lung disease: genes may hold the key
- New study tracks lung disease in rheumatic patients
- Lung biopsy without a breathing tube? small study tests a gentler approach
- New injection aims to ease lung pressure in scarred lungs